- Aerie Pharmaceuticals (NASDAQ:AERI) announces that it has priced its registered underwritten public offering of $75M of shares of its common stock at a price of $53.75 per share. The offering was upsized by $25M over the anticipated offering amount in addition to the $50M of its common stock sold through the at-the-market (ATM) program.
- Closing date is June 1.
- Net proceeds will be used for general corporate purposes, for working capital and for the expansion of its external business development programs.